Literature DB >> 2055727

Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat.

R H Cohan1, R A Leder, A J Herzberg, L W Hedlund, C T Wheeler, C A Beam, S N Nadel, N R Dunnick.   

Abstract

We compared the relative toxicities of standard concentrations of two magnetic resonance imaging (MRI) contrast agents, ionic gadolinium diethylenetriaminepentacetic acid (DTPA) and low-osmolar gadolinium-1, 4, 7 tris (carboxymethyl)-10-(2'-hydroxypropyl)-1, 4, 7, 10 tetra-azacyclododecane (HP-DO3A) with that of the conventional radiographic contrast medium meglumine diatrizoate, when extravasated into the deep dermal tissues of laboratory rats. Gadolinium-DTPA caused moderate necrosis, hemorrhage, and edema which was not statistically different than meglumine diatrizoate. In contrast, gadolinium HP-DO3A was significantly less toxic than meglumine diatrizoate. Additional experience will be needed in order to determine whether these laboratory results will be clinically relevant in humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055727     DOI: 10.1097/00004424-199103000-00005

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  10 in total

1.  High-resolution MR lymphangiography for planning lymphaticovenous anastomosis treatment: a single-centre experience.

Authors:  Maria Antonietta Mazzei; Francesco Gentili; Francesco Giuseppe Mazzei; Paolo Gennaro; Duccio Guerrieri; Andrea Nigri; Guido Gabriele; Elisabetta Weber; Alfonso Fausto; Giuseppe Botta; Luca Volterrani
Journal:  Radiol Med       Date:  2017-08-02       Impact factor: 3.469

2.  MR-lymphangiography at 3.0 T--a feasibility study.

Authors:  Mike Notohamiprodjo; Ruediger G H Baumeister; Tobias F Jakobs; Kerstin U Bauner; Holger F Boehm; Annie Horng; Maximilian F Reiser; Christian Glaser; Karin A Herrmann
Journal:  Eur Radiol       Date:  2009-06-06       Impact factor: 5.315

3.  [Development of compartment syndrome after intravenous administration of an X-ray contrast medium. Recommendations on acute therapy regimens].

Authors:  N Hawi; M Citak; E Liodakis; M Petri; C Haasper; C Krettek; R Meller
Journal:  Unfallchirurg       Date:  2014-04       Impact factor: 1.000

Review 4.  Exposure, metabolism, and toxicity of rare earths and related compounds.

Authors:  S Hirano; K T Suzuki
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

Review 5.  Currently used non-specific extracellular MR contrast media.

Authors:  M F Bellin; M Vasile; S Morel-Precetti
Journal:  Eur Radiol       Date:  2003-06-19       Impact factor: 5.315

6.  Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.

Authors:  E A Wallnöfer; G C Thurner; C Kremser; H Talasz; M M Stollenwerk; A Helbok; N Klammsteiner; K Albrecht-Schgoer; H Dietrich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2020-10-11       Impact factor: 4.304

7.  Phase III clinical evaluation of gadoteridol injection: experience in pediatric neuro-oncologic MR imaging.

Authors:  J F Debatin; S N Nadel; L Gray; H S Friedman; P Trotter; B Hockenberger; W J Oakes
Journal:  Pediatr Radiol       Date:  1992

8.  Imaging lymphatic system in breast cancer patients with magnetic resonance lymphangiography.

Authors:  Qing Lu; Jia Hua; Mohammad M Kassir; Zachary Delproposto; Yongming Dai; Jingyi Sun; Mark Haacke; Jiani Hu
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

9.  MR Lymphangiography: A Practical Guide to Perform It and a Brief Review of the Literature from a Technical Point of View.

Authors:  Francesco Giuseppe Mazzei; Francesco Gentili; Susanna Guerrini; Nevada Cioffi Squitieri; Duccio Guerrieri; Paolo Gennaro; Michele Scialpi; Luca Volterrani; Maria Antonietta Mazzei
Journal:  Biomed Res Int       Date:  2017-03-07       Impact factor: 3.411

10.  Intravenous contrast medium extravasation: systematic review and updated ESUR Contrast Media Safety Committee Guidelines.

Authors:  Giles Roditi; Nadir Khan; Aart J van der Molen; Marie-France Bellin; Michele Bertolotto; Torkel Brismar; Jean-Michel Correas; Ilona A Dekkers; Remy W F Geenen; Gertraud Heinz-Peer; Andreas H Mahnken; Carlo C Quattrocchi; Alexander Radbruch; Peter Reimer; Laura Romanini; Fulvio Stacul; Henrik S Thomsen; Olivier Clément
Journal:  Eur Radiol       Date:  2022-02-17       Impact factor: 7.034

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.